MYX mayne pharma group limited

Target $0.73, page-9

  1. 3,781 Posts.
    lightbulb Created with Sketch. 310
    In sum, Macquarie estimates a valuation of $0.20 per share, raising the target to $0.66 from $0.51 and, with an implied total shareholder return of 5% based on the new target, upgrades to Neutral from Underperform.


    See? All brokers are only doing all these after the fact.. If we follow their guidance, we are doomed...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.01
Change
-0.240(4.57%)
Mkt cap ! $407.0M
Open High Low Value Volume
$5.17 $5.18 $5.01 $636.5K 125.5K

Buyers (Bids)

No. Vol. Price($)
3 1805 $5.01
 

Sellers (Offers)

Price($) Vol. No.
$5.03 666 8
View Market Depth
Last trade - 13.45pm 29/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.